18 F-Fluoride PET allows noninvasive evaluation of regional bone metabolism and has the potential to become a useful tool for assessing patients with metabolic bone disease and evaluating novel drugs being developed for these diseases. The main PET parameter of interest, termed K i , reflects regional bone metabolism. The aim of this study was to compare the long-term precision of 18 F-fluoride PET with that of biochemical markers of bone turnover assessed over 6 mo. Methods: Sixteen postmenopausal women with osteoporosis or significant osteopenia and a mean age of 64 y underwent 18 F-fluoride PET of the lumbar spine and measurements of biochemical markers of bone formation (bone-specific alkaline phosphatase and osteocalcin) and bone resorption (urinary deoxypyridinoline) at baseline and 6 mo later. Four different methods for analyzing the 18 F-fluoride PET data were compared: a 4k 3-compartmental model using nonlinear regression analysis (K i-4k ), a 3k 3-compartmental model using nonlinear regression analysis (K i-3k ), Patlak analysis (K i-PAT ), and standardized uptake values. Results: With the exception of a small but significant decrease in K i-3k at 6 mo, there were no significant differences between the baseline and 6-mo values for the PET parameters or biochemical markers. The long-term precision, expressed as the coefficient of variation (with 95% confidence interval in parentheses), was 12.2% (9%-19%), 13.8% (10%-22%), 14.4% (11%-22%), and 26.6% (19%-40%) for K i-3k , K i-PAT , mean standardized uptake value, and K i-4k , respectively. For comparison, the precision of the biochemical markers was 10% (7%-15%), 18% (13%-27%), and 14% (10%-21%) for bone-specific alkaline phosphatase, osteocalcin, and urinary deoxypyridinoline, respectively. Intraclass correlation between the baseline and 6-mo values ranged from 0.44 for K i-4k to 0.85 for K i-3k . No significant correlation was found between the repeated mean standardized uptake value measurements. Conclusion: The precision and intraclass correlation observed for K i-3k and K i-PAT was equivalent to that observed for biochemical markers. This study provided initial data on the long-term precision of 18 F-fluoride PET measured at the lumbar spine, which will aid in the accurate interpretation of changes in regional bone metabolism in response to treatment. The functional imaging technique of 18 F-fluoride PET allows a direct quantitative assessment of bone metabolism at specific sites of the skeleton (1-12). In the early 1990s, when 18 F-FDG PET was evolving as a major tool in the field of oncology, 18 F-fluoride PET was introduced as a technique for quantifying bone metabolism by Hawkins et al., who first described the 3-compartmental kinetic model that can be applied in clinical studies (7). Like 18 F-FDG PET, 18 Ffluoride PET has several methods for quantitation, ranging from simple semiquantitative measures to methods that require complex protocols for scan acquisition (13,14).18 F-Fluoride PET has been validated by direct comparison with the gold st...